Mirtazapine Tablet, Film Coated
Product Images NDC 71335-3038

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71335-3038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713353038)

The given text details a medication named Mirtazapine in tablet form with a strength of 7.5 mg. It provides instructions for proper storage, including storing at 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication is to be dispensed in a light-resistant container as per USP guidelines. It also mentions the importance of distributing a Medication Guide to each patient. The tablets are labeled for prescription use only and should be kept out of reach of children. The manufacturer information indicates that the tablets are relabeled by Bryant Ranch Prepack, Inc and manufactured by Aurobindo Pharma Limited.*

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.